Skip to main content
. 2016 Aug 18;354:i4189. doi: 10.1136/bmj.i4189

graphic file with name flew032618.f2_default.jpg

Fig 2 Distribution of payments by pharmaceutical manufacturer to physicians, and physician prescribing of marketed drugs among Medicare Part D beneficiaries for non-insulin diabetes drugs, by hospital referral region. Payments per 1000 person years of Part D coverage for non-insulin diabetes drugs (top panel); market share (%) of marketed non-insulin diabetes drugs (bottom panel)